• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • Virtual Data Room (VDR) for Strategic Customized Slide Decks
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Certificate One Year

All INTERNSHIPS are TUITION FREE on a VOLUNTEER basis and involve a One Year Academic Training in the following areas.

LPBI Group will run SIX MAJOR INTERNSHIPS: Volunteer base

  • We Offer esteemed Affiliation, Mentorship by Scientists
  • NEW skills development in NLP, ML, AI applications to Medical Text and Drug Discovery
  • References and Resume paragraph on accomplishments and goals during the INTERNSHIP
  • Opportunity to contribute to Publications
  • Explorations of opportunities in Life Sciences in the US

 

INTERNS at LPBI Group progressed their careers with our Letter of Recommendation upon completion of an Internship:

  • Madison Davis got admission to Harvard University. For Summer 2023, I submitted two Letters of Recommendation for two Programs in CS
  • Danielle Smolyar got Admission at Tufts University, Dental School
  • Abhisar Anand – got my LOR for College admission
  • Srini Sriram – got my LOR for 2023 Summer Program in CS
  • Pati Premalata, PhD – got my LOR and obtained admission to MS program in Bioinformatics and Computational Biology at the University of South Florida for this Spring 2023

And

  • Adam Sonnenberg arrived with BSc, April 2015, published 7 books for LPBI by format conversion. He pursued PhD and now is completing MD
  • SEE LPBI Logo on his CV

https://www.linkedin.com/in/adam-sonnenberg-phd-26b75095/

  • Each of you need to have LPBI Logo on your CV

 

 

LPBI Group runs FOUR ACADEMIC INTERNSHIPS: Volunteer base

  • TWO INTERNSHIPS in LIFE SCIENCES, Medicine, Biological Sciences, Drug Discovery

Advertisementshttps://c0.pubmine.com/sf/0.0.3/html/safeframe.htmlREPORT THIS AD

#1: Text Analysis [Medical] with Wolfram: Natural Language Processing with a NEW cohort of INTERNS and our Summer Interns that will choose to stay

  • https://pharmaceuticalintelligence.com/2020-summer-internship/
  • https://pharmaceuticalintelligence.com/2021-medical-text-analysis-nlp/

#2: Synthetic Biology Software for Drug Design in Glycobiology for our Joint Venture with ABI-LAB, with Dr. Raphael Nir, PhD, President & CSO

#3: ONE INTERNSHIP is in  Journalism in Pharmaceutical MEDIA & Web Design and Marketing Communications 

#4: ONE INTERNSHIPS is in IS, IT, CS and DATA SCIENCE

IT Project and Administration of IP Asset Classes: Journal, Books, e-Proceedings & Tweet Collections and GALLERY of +6,200 Biological Images

BLOCKCHAIN Architecture design: Interface for NLP. The powerful aspect is hydrating a knowledge graph with NLP inferences so that they can be used for DISCOVERY. Storing those inferences on a blockchain have the value of committing the NLP inferences to a blockchain for purposes of provenance. However, the very important part is The INFRASTRUCTURE behind BurstIQ which is NOT JUST A BLOCKCHAIN [the voice of Erich G.]

  • 2020/2021 LPBI Plan for IT Projects & Reseach Projects – LPBI’s TASKS for Research Assistants & Associates

Detailed description to be found on each Internship page, below

  • Medical Text Analysis (Deep Learning NLP)
  • IS, IT, CS and Data Science Internship
  • Blockchain Knowledge Graph Database Design with Interface to Wolfram NLP
  • Finance Internship: Financial Modeling
  • Synthetic Biology Software for Drug Design in Glycobiology Internship
  • Journalism and Marketing Communications in Pharmaceutical Media

 

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading…

This page has the following sub pages.

  • Medical Text Analysis (Deep Learning NLP)
  • IS, IT, CS and Data Science Internship
  • Blockchain Knowledge Graph Database Design with Interface to Wolfram NLP
  • Finance Internship: Financial Modeling
  • Synthetic Biology Software for Drug Design in Glycobiology Internship
  • Journalism and Marketing Communications in Pharmaceutical Media

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,041 other subscribers
  • Recent Posts

    • AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
    • In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
    • Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
    • 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
    • Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
    • Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
    • A Systematic Analysis of Competitive Dynamics in the AI Revolution — Strategic Relevance to LPBI Group’s Mission – Alex Wissner-Gross Daily Newsletters by KOL (March 1 – June 10, 2026, to be extended to Present) June 11, 2026
    • In Memoriam: Professor Yitzhak Apeloig, President and Distinguised Professor of the Technion June 4, 2026
    • Top VC Investors in AI / Health AI in 2026 May 26, 2026
    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


Loading Comments...
%d